Re "The market is forward-looking so if revenue deals start...

First 19 Last

Share
Profile

Follow
largeraj

1,213 Posts.

389

03/09/19

23:56

Post #: 40299364
Share

Originally posted by runaway: ↑

Honestly it all comes down to revenue if you're talking about 'Disallowed' from here. RAP has amazing scalability. Loads of potential to make huge net profit. P/E ratios in this field could make it more than a Disallowed. I think with FDA approval it should be trading around 35-40c. Once revenue rolls in it could be a Disallowed or more from this current share price.

Assuming all regulatory approvals are in place within the next 6 months and deals start being made also in that time. Let's say RAP makes $100m net profit in 3 years time at P/E of 20 (reasonable assumption for this industry), maybe the outstanding amount of shares by then is a even 800m for performance shares etc. The market cap would be $2b and share price $2.5.

The market is forward-looking so if revenue deals start gaining traction it could reach a really high share price in a short amount of time. Personally I think FDA approval will definitely happen. Like I've said before the company will re-rate hard when it starts making money.
Agreed

Expand

Re "The market is forward-looking so if revenue deals start gaining traction it could reach a really high share price in a short amount of time."
History shows you are right, and without intending to cross-promote, one only has to see what is happening to ISX right now (I hold it long term as well as RAP long term), once serious revenue finally got underway. I hope and expect exactly the same scenario for RAP, as I'm sure all of us patient long term RAP holders do too, that is why we have been loyal holders for so long (I'm in RAP since 2015).

RAP Price at posting: 22.0¢ Sentiment: Buy Disclosure: Held
19 Upvote

0 Great analysis

Reply